Skip to main content
Fig. 3 | Journal of Experimental & Clinical Cancer Research

Fig. 3

From: Plasmacytoid dendritic cells at the forefront of anti-cancer immunity: rewiring strategies for tumor microenvironment remodeling

Fig. 3

Tissue pDCs are mostly negative for CD2, CD5, and PD-L1. Sections are from reactive lymph nodes (LN) (a-f; representative images from 2 out of 5 cases analyzed) and cutaneous lupus erythematosus (LE) (g-i; representative images of 1 out of 3 cases analyzed) and stained with TCF4/E2.2, CD2, CD5, and PD-L1, as labeled. Magnification 400x; scale bar 50 µm

Back to article page